TherapyXinc

NANOPARTICULATE IMMUNE THERAPEUTICS TO TREAT CANCER, INFECTIOUS DISEASE AND AUTOIMMUNE DISORDERS.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Louisville, KY, US
  • Currency USD
  • Founded May 2000
  • Employees 7
  • Incorporation Type S-corp
  • Website therapyXinc.com

Company Summary

TherapyX, Inc. is advancing the development and commercialization of nanoencapsulated immune-modulatory biologics (NanoCapTM) for the treatment of autoimmune/inflammatory diseases, cancer and infection. The company’s Phase Inversion Nanoencapsulation (PIN) technology provides a customizable platform for the development of sustained-release nanoparticulate protein formulations. Our most advanced products are TGFβ NanoCapTM and IL12 NanoCapTM.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free